SEC Form D private-offering filing

Lexaria Bioscience Corp.

A new SEC Form D private-offering notice from Kelowna, BC, Canada, a $3,500,004 filer-stated offering target in Biotech. The source filing is one click away.

Lexaria Bioscience Corp. site↗ Verified via SEC Form D

Biotechnology company developing DehydraTECH, a drug delivery technology that improves bioavailability of active pharmaceutical ingredients.

Filed 2025-12-19Filed to raise $3,500,004First money in 2025-12-16Raised so far $3,500,004HQ (as filed) Kelowna, BC, CanadaSector Biotech Stage (inferred) SeedCall status Needs classification
Source linked the Form D on EDGAR↗Website verified lexariabioscience.com↗Named in the filing 8 executives & directors

This is a public SEC Form D private-offering notice, the filer's own statement to the SEC. Amounts are offering targets, not confirmed closes. Takeoff Radar pulls Form D nightly from EDGAR and links every filing to its source.